← Leaderboards
Jose Francisco Huizar
Virginia Commonwealth University
$2,594,731
Attributed
$3,120,758
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $886K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,120,758 · 3
VA$0 · 3
By mechanism
R01$2,013,004 · 1
R34$601,174 · 1
R56$506,580 · 1
I01$0 · 2
IS1$0 · 1
Top collaborators
- Teresa De Marco3 shared
- Kenneth Alan Ellenbogen3 shared
- Edward Paul Gerstenfeld3 shared
- John Gorcsan3 shared
- William Gregory Hundley3 shared
- Carlos Morillo3 shared
- Adam Paul Sima3 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Gea-Ny Tseng$8,971,144
- Beatrix Magdalena Ueberheide$5,559,560
- Xuewei Wang$1,891,224
- Frank J Raucci$859,692
- William Gregory Hundley$19,718,962
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacPreventHeart FailureCardiomyopathiesDesignAdmission ActivityVentricular Premature ComplexesHealthcareFunctional DisorderRandomizedMortalitySecondary ToStructureVeteransResponseAcuteAnimalsAnimal ModelFamily SuidaeEvaluationPacemakersPathway InteractionsCouplingImplant
Grant awards (17)
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model$0
I01 · FY2024 · VA · contact PI
Novel in situ custom biodegradable drug-eluting stents for endovascular surgery$0
I01 · FY2024 · VA · contact PI
LV dyssynchrony and fibroblast activation in PVC-induced Cardiomyopathy$0
I01 · FY2023 · VA · contact PI
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model$0
I01 · FY2023 · VA · contact PI
Novel in situ custom biodegradable drug-eluting stents for endovascular surgery$0
I01 · FY2023 · VA · contact PI
Novel in situ custom biodegradable drug-eluting stents for endovascular surgery$0
I01 · FY2022 · VA · contact PI
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model$0
I01 · FY2022 · VA · contact PI
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model$0
I01 · FY2021 · VA · contact PI
Research-Dedicated Magnetic Resonance Imaging at McGuire VA Medical Center$0
IS1 · FY2021 · VA · contact PI
Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy$650,046
R01 · FY2020 · HL · contact PI
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model$0
I01 · FY2020 · VA · contact PI
Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy$675,918
R01 · FY2019 · HL · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$166,124
R34 · FY2019 · HL · contact PI
Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy$687,040
R01 · FY2018 · HL · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$199,003
R34 · FY2018 · HL · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$236,047
R34 · FY2017 · HL · contact PI
Mechanistic Insight of Premature Ventricular Contractions-induced Cardiomyopathy$506,580
R56 · FY2016 · HL · contact PI